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Available online 19 August 2005Abstract—A novel and efficient procedure to prepare highly oxidised aryltetralin lignans, such as isopodophyllotoxone and ()-aris-
tologone derivatives, by oxidation of podophyllotoxin and galbulin with methylrhenium trioxide (MTO) and novel MTO hetero-
geneous catalysts is reported. It is noteworthy that in the case of isopodophyllotoxone derivatives the functionalisation of the
C-4 position of the C-ring and the ring-opening of the D-lactone moiety increased the activity against topoisomerase II while caus-
ing the undesired inhibition of tubulin polymerisation to disappear. The novel ()-aristologone derivatives showed apoptogenic
activity against resistant human lymphoma cell lines.
 2005 Elsevier Ltd. All rights reserved.1. Introduction
Lignans are a family of natural products with a broad
variety of biological and pharmacological activities.1
Among them, aryltetralin derivatives are of special
interest owing to their powerful antitumoral, antimitot-
ic, antiviral, cardiovascular and immunosuppressive
activity.2 Aryltetralin derivatives show also a selective
nonredox inhibition of 5-lipoxygenase by interaction
with the arachidonic acid binding site and could form
a new class of therapeutic agents for the treatment of
asthma and rheumatoid arthritis.3 Podophyllotoxin 1,
isolated from different plants of the genus Podophyl-
lum, is the most investigated aryltetralin derivative.
It is a well-established inhibitor of cell division at
the level of the microtubule assembly by freezing poly-
merisation of tubulin at the colchicine site.4 This activ-
ity has led to the design of semi-synthetic derivatives,
such as etoposide (40-demethyl-7-[4,6-O-ethylidene-b-D-
gluco-pyranosyl epipodophyllotoxin) and teniposide
(40-demethyl-7-[4,6-O-thenilidene-b-D-glucopyranosyl epip-0968-0896/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
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242; e-mail: saladino@unitus.itodophyllotoxin), which have been widely used for the
treatment of small-cell lung cancer, testicular cancer,
lymphoma and acute lymphocytic leukaemia.5 Etopo-
side and teniposide show different side effect profiles
compared to podophillotoxin due to their action as
selective inhibitors of DNA topoisomerase II, a key
enzyme involved in DNA transcription, replication,
recombination and possibly DNA repair.6 In recent
years, several syntheses of podophyllotoxin and
aryltetralin lignan derivatives have been reported in
the literature which mainly focused on structural mod-
ifications of leader molecules to obtain less toxic ana-
logues with high biological activities. On the other
hand, a few data are available on oxidative functionali-
sation,7 a process that plays a relevant role in their
biological mechanism of action. For example, it is
known that etoposide undergoes oxidative ortho-
demethylation by a cytochrome P450-dependent meta-
bolic process to a 3 0,4 0-dihydroxy derivative.8 This
derivative is further oxidised to the corresponding
ortho-benzoquinone, a highly reactive intermediate
responsible for the irreversible binding to proteins
and DNA.9 In a similar way, a semibenzoquinone free
radical intermediate of etoposide is responsible for
DNA strand breakage.10 Since general and selective
methods for the oxidation of aryltetralin lignans are
still lacking,11 novel synthetic strategies are needed to
